Charles Schwab Investment Management Inc. boosted its stake in Catalent, Inc. (NYSE:CTLT – Free Report) by 1.1% during the ...
Seeking Alpha on MSN6d
Catalent gains on reports it's likely to be granted EU approval for Novo Holdings deal (update)Update 12:35pm: Adds Reuters report. Catalent (NYSE:CTLT) rose 2.2% amid reports that the European Union's antitrust ...
Zacks.com on MSN15d
JAZZ or CTLT: Which Is the Better Value Stock Right Now?Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors? We'll need ...
Baird has recently raised Catalent Inc (CTLT) stock to Outperform rating, as announced on November 16, 2023, according to Finviz. Earlier, on September 5, 2023, Argus had raised the stock from a Hold ...
CTLT opened at $60.98 on Friday. The business has a 50 day moving average price of $59.81 and a two-hundred day moving average price of $58.31. The company has a debt-to-equity ratio of 1.38, a ...
There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.
Catalent (NYSE:CTLT) rose 2% amid a report that the European Union's antitrust regulator will likely grant approval for its ...
Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback